Trends in childhood asthma hospitalisation in three Asia Pacific countries

被引:2
|
作者
Chua, Kun Lin [1 ,3 ]
Ma, Stefan [2 ]
Prescott, Susan [4 ]
Ho, Marco H. K. [5 ]
Ng, Daniel K. [6 ]
Lee, Bee Wah [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119074, Singapore
[2] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore
[3] Univ Melbourne, Sch Med, Melbourne, Vic, Australia
[4] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia
[5] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
[6] Kwong Wah Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China
关键词
asthma; child; hospitalisation; 1ST; 6; YEARS; INHALED CORTICOSTEROIDS; WHEEZING PHENOTYPES;
D O I
10.1111/j.1440-1754.2011.02040.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: The study aims to examine recent childhood asthma hospitalisation rates in the Asia Pacific countries of Australia, Hong Kong and Singapore. On the background of reported decline in many countries with high asthma prevalence during late 1990s. Methods: Annual asthma hospitalisation (ICD9-CM: 493 or ICD10-AM: J45-46)* and population data from 1994 to 2008, of children aged 0-14 years old, were obtained from the Australian National Hospital Morbidity Database, from the Hospital Authority in Hong Kong and from the Ministry of Health in Singapore. Data were stratified in two age groups: 0-4 and 5-14 years old, and also in different periods of calendar years. Time-series regression analyses were used to examine temporal trends. Diagnostic transfer was addressed by examining bronchitis hospitalisations. Results: Significant decreases of up to 6.5% per annum in childhood asthma hospitalisation rates were found over the study period. However, the latter half of the study period showed increases in hospitalisation rates in all countries studied. No evidence of diagnostic transfer was found. Conclusion: Although there has been a decrease in childhood asthma hospitalisation rates since the 1990s, a modest increase was observed from 2003 to 2008. Ongoing monitoring is required.
引用
收藏
页码:723 / 727
页数:5
相关论文
共 50 条
  • [21] Asthma control in adults in Asia-Pacific
    Zainudin, BMZ
    Lai, CKW
    Soriano, JB
    Jia-Horng, W
    De Guia, TS
    RESPIROLOGY, 2005, 10 (05) : 579 - 586
  • [22] Asthma management in the Asia-Pacific region
    Beckert, Lutz
    Moran, Angela
    RESPIROLOGY, 2014, 19 (01) : 1 - 2
  • [23] Burden of smoking in Asia-Pacific countries
    Lee, Vivian W. Y.
    Li, Anna
    Li, Joyce T. S.
    TOBACCO INDUCED DISEASES, 2021, 19
  • [24] Resource management in Asia Pacific developing countries
    Hardaker, JB
    AUSTRALIAN JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS, 2002, 46 (04) : 634 - 637
  • [25] Corruption, democracy and Asia-Pacific countries
    Campbell, Neil
    Saha, Shrabani
    JOURNAL OF THE ASIA PACIFIC ECONOMY, 2013, 18 (02) : 290 - 303
  • [26] Financing health insurance in Asia Pacific countries
    Sidorenko, Alexandra A.
    Butler, James R. G.
    ASIAN-PACIFIC ECONOMIC LITERATURE, 2007, 21 (01) : 34 - 54
  • [27] METALS DEMAND IN THE PACIFIC RIM COUNTRIES OF ASIA
    TILTON, JE
    NATURAL RESOURCES FORUM, 1989, 13 (03) : 198 - 203
  • [28] Asia Pacific Stroke Conference 2020: Bringing Innovation to Stroke Care in Asia Pacific Countries
    Tan, Kay Sin
    Kwon, Sun U.
    Jung, Keun Hwa
    Rha, Joung Ho
    Yoon, Byung Woo
    Venketasubramanian, Narayanaswamy
    CEREBROVASCULAR DISEASES, 2020, 49 (SUPPL 1) : III - IV
  • [29] Prevalence of asthma in Asia - Comparison with Western countries
    Lee, HB
    ALLERGY: AN EXPANDING CHALLENGE IN THE 21ST CENTURY, 2002, : 11 - 17
  • [30] Regulatory Trends in Drug Development in Asia Pacific
    Fengyun Vicky Han
    Karen Weiss
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 497 - 501